MD Anderson receives $20M donation from Belfer family to study neurodegeneration

CTMC and Einstein Hospital Israelita in Brazil partner to launch the Global Cell Therapy Network Alliance

CTMC, a joint venture between Resilience and MD Anderson Cancer Center, has entered into a collaborative partnership with Einstein Hospital Israelita in Sao Paulo, Brazil, aimed at accelerating the adoption of cell therapy in Brazil and all of Latin America.

October 17, 2025

Vol.51 No.38

Guest Editorial

Championing nurse wellbeing as a strategic priority

Working in a comprehensive cancer center requires emotional endurance, strong clinical judgment, and constant interprofessional collaboration, all of which rest on a foundation of personal wellness. For nurses, whose roles are inherently intensive, focusing on wellbeing is integral to their ability to provide safe, compassionate, and effective patient care.

September 26, 2025

Vol.51 No.35

By Kim Slusser

Clinical Roundup

ALOX15 loss, common in CRC, impairs the cancer-preventative effects of fish oil, mouse study shows

About 19 million American adults consume dietary fish oil supplements. These supplements, which primarily consist of the omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid, are widely used as a remedy for chronic diseases. However, the effects of EPA and DHA supplementation on cancer risk have been inconsistent.

September 26, 2025

Vol.51 No.35

In Brief

VCU Massey, MD Anderson researchers awarded $7.3M grant to launch breast cancer clinical trial

Venkata Lokesh BattulaClinton YamA multidisciplinary team of researchers at VCU Massey Comprehensive Cancer Center and MD Anderson Cancer Center has been awarded a $7.3 million grant from the U.S. Department of Defense to fund a novel clinical trial targeting one of the most aggressive and hard-to-treat forms of breast cancer: metastatic triple-negative breast cancer.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Novel tool helps identify key targets to strengthen CAR NK cell therapies, MD Anderson research shows

Natural killer cells became markedly better at killing cancer cells after scientists removed key gene targets identified through a new genome-wide CRISPR screening tool, according to new research from the University of Texas MD Anderson Cancer Center.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance

Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation leading to immune exhaustion and eventual resistance to immunotherapy, according to a study led by researchers at The University of Texas MD Anderson Cancer Center.

September 05, 2025

Vol.51 No.32

MD Anderson receives $20M donation from Belfer family to study neurodegeneration

YOU MAY BE INTERESTED IN

CTMC and Einstein Hospital Israelita in Brazil partner to launch the Global Cell Therapy Network Alliance

Championing nurse wellbeing as a strategic priority

ALOX15 loss, common in CRC, impairs the cancer-preventative effects of fish oil, mouse study shows

VCU Massey, MD Anderson researchers awarded $7.3M grant to launch breast cancer clinical trial

Novel tool helps identify key targets to strengthen CAR NK cell therapies, MD Anderson research shows

Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance

Renew today!

Subscriber content

Never miss an issue!

Login